Item 1.02 Termination of a Material Definitive Agreement.
Effective September 29, 2012, Galectin Therapeutics Inc. (the "Company")
terminated its Collaboration, Supply, Marketing and Distribution Agreement,
dated October 18, 2011 (the "Agreement"), with PROCAPS, S.A ("PROCAPS") due to a
material breach, as PROCAPS had not obtained regulatory approval of GM-CT-01 in
Colombia by the required date in accordance with the terms of the Agreement. A
description of the material terms of the Agreement are contained in the Form 8-K
filed by the Company on October 24, 2011, and the Agreement is filed as Exhibit
10.2 to the Company's Form 10-Q for the quarter ended September 30, 2011, both
of which are incorporated herein by reference.
Add
GALT to Portfolio
Set Alert
Email to a
Friend